Viruses · 2020 · 113 citations · 15 references
Life SciencesInfectious DiseasesMicrobiologyMedical MicrobiologyMolecular VirologyVirologyAntiviral AgentsAntiviral TherapyInfectious Disease Molecular TestingViral DiagnosticsVirus PurificationVirus RemovalBiosafetyCoronavirus DiagnosticsDetergent TreatmentDetergentsRna ExtractionSample LysisSars-cov-2 InfectionViral Risk Assessment
Clinical samples collected in coronavirus disease 19 (COVID-19), patients are commonly manipulated in biosafety level 2 laboratories for molecular diagnostic purposes. Here, we tested French norm NF-EN-14476+A2 derived from European standard EN-14885 to assess the risk of manipulating infectious viruses prior to RNA extraction. SARS-CoV-2 cell-culture supernatant and nasopharyngeal samples (virus-spiked samples and clinical samples collected in COVID-19 patients) were used to measure the reduction of infectivity after 10 minute contact with lysis buffer containing various detergents and chaotropic agents. A total of thirteen protocols were evaluated. Two commercially available formulations showed the ability to reduce infectivity by at least 6 log 10, whereas others proved less effective.
15
Features, Evaluation and Treatment Coronavirus (COVID-19)
Marco Cascella, Michael Rajnik, Arturo Cuomo et al. · StatPearls · 2020 · 3.3K citations
Sean Wei Xiang Ong, Yian Kim Tan, Po Ying Chia et al. · JAMA · 2020 · 2.3K citations · Full text
Viral load of SARS-CoV-2 in clinical samples
Yang Pan, Daitao Zhang, Peng Yang et al. · The Lancet Infectious Diseases · 2020 · 1.7K citations · Full text